XTLB Stock Summary and Trading Ideas (XTL Biopharmaceuticals Ltd. - American Depositary Shares | NASDAQ:XTLB)

XTL Biopharmaceuticals Ltd is an intellectual property-based company focused on the development, management, and commercialization of intellectual property. The Company is engaged in biotechnology through its subsidiary Psyga Bio and in the biopharmaceutical industry with hCDR1, a novel compound working via a novel mechanism of action for the treatment of Systemic Lupus Erythematosus (SLE) and a potential treatment for Sjogren's syndrome (SS). It focuses on the acquisition and development of proprietary products and late-stage pharmaceutical product candidates for the treatment of unmet clinical needs.

XTL Biopharmaceuticals Ltd. - American Depositary Shares trades on the NASDAQ stock market under the symbol XTLB.

As of July 14, 2026, XTLB stock price climbed to $2.96 with 43,699 million shares trading.

XTLB has a beta of 1.39, meaning it tends to be more sensitive to market movements. XTLB has a correlation of 0.03 to the broad based SPY ETF.

XTLB has a market cap of $7.27 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, XTLB traded as high as $19.96 and as low as $2.01.

XTLB has underperformed the market in the last year with a return of -51.0%, while SPY returned +21.8%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in XTLB shares. However, XTLB has outperformed the market in the last 3 month and 2 week periods, returning +23.6% and +25.4%, while SPY returned +9.9% and +1.5%, respectively. This indicates XTLB has been having a stronger performance recently.

XTLB support price is $2.58 and resistance is $3.18 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that XTLB shares will trade within this expected range on the day.